Indefinite Delivery Contract 36C25624D0025

Award Date 12/20/23
Last Date to Order 12/19/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded Biomerieux Inc. multiple blanket purchase agreements and call contracts from April 2023 through September 2024 totalling approximately $215,000. Biomerieux Inc. will provide VIDAS diagnostic testing platforms, reagents, and related services as the prime contractor. Performance will occur at Biomerieux's facility in Emigration Canyon, Utah to support infectious disease testing for...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a Blanket Purchase Agreement (BPA) by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration under its Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III). The BPA and subsequent task orders, valued at over $1.4 million, provide the VA with Biomerieux's specialized microbiology testing platforms, reagents, test kits, and technical support services for blood culture...
Biomerieux Inc. is providing clinical diagnostic products and services under a multiple award Federal Supply Schedule contract issued by the Department of Veterans Affairs Veterans Health Administration. The IDV has a potential value of $66.7M through December 2026. Task orders awarded to Biomerieux include delivery of proprietary microbiology analyzers, reagents, test kits and consumables. Services include cost-per-test for identification and antibiotic susceptibility testing to support...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23. The contract, valued at $135,660.00, is for the maintenance and support of Biomerieux's specialized diagnostic equipment and platforms installed at VA healthcare facilities. The contract has an ultimate completion date of September 30, 2027, with the first two task orders valued at...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 2, has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc. for the procurement of VIDAS 3 reagents and consumables. This single-award IDV contract, valued at $83,455.26, will support the continued use of VIDAS 3 instrumentation at the James J. Peters VA Medical Center (JJPVAMC) and Northport VA Medical Center. As the sole authorized distributor and Original Equipment Manufacturer (OEM) of the VIDAS 3...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 (VISN 10) to Biomerieux Inc., a global leader in in vitro diagnostics. The $1,977,723.92 single-award BPA, which falls under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, is for the provision of analyzers, reagents, and consumables to support the agency's critical laboratory testing requirements. The contract includes two BPA calls, valued...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award, indefinite delivery contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide bacterial identification and antibiotic susceptibility testing services to the VA's Veterans Integrated Service Network 2 (VISN 2). The contract, valued at a ceiling of $2,366,377.51, has an ultimate completion date of March 31, 2026 and does not utilize any set-aside designations. Under this IDC, Biomerieux Inc., through...
  • 36C25624D0025
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

This indefinite delivery contract award to Biomerieux Inc. by the Department of Veterans Affairs Veterans Integrated Service Network 16 provides a $117,240 firm fixed price delivery order for the company's VIDAS 3 Analyzer System. The analyzers will be used to support procalcitonin (PCT) and NephroCheck testing at the Michael E. DeBakey VA Medical Center in Houston, Texas over a five-year period through 2028.

The original solicitation sought these specific VIDAS 3 analyzer reagents and consumables to enable rapid pathogen detection and kidney function assessment for veterans receiving care within the VA network. As a sole source provider of its proprietary diagnostic platforms, Biomerieux was able to meet the agency's exact requirements without the use of any set-aside designations. This contract is part of Biomerieux's broader portfolio of federal supply schedule agreements and blanket purchase agreements that facilitate ongoing procurement of its advanced in vitro diagnostic solutions across multiple government healthcare agencies.

Generated 8/1/24, 9:07 AM